News & Events

  • Important step in the research of RNAi therapeutics

    Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced that they have achieved delivery of novel small interfering RNA (siRNA) conjugates to the central nervous system (CNS) and are planning to advance a pipeline of investigational RNAi therapeutics into clinical development. The conjugates achieved robust, durable, and broadly...
    Read more
  • 2nd edition of B-SMART newsletter available!

    We are happy to announce the second edition of our B-SMART newsletter. It contains information on the first results of the project as well as news from the consortium and events announcements. Please have a look at B-SMART Newsletter // Issue No 2 // April 2018 and enjoy reading!
    Read more
  • First results!

    B-SMART has achieved first results in the development of RNA-based nanomedicines to treat neurodegenerative diseases. The scientists succeeded in developing an effective nanoparticle with customisable characteristics which is now being tested in a preclinical trial. In order to ensure scalability and a safe transfer of the scientific results to...
    Read more
  • Out now: The B-SMART animated clip is online

    We have released a short animated clip illustrating the project goals in an entertaining and understandable way, as well as highlighting the expected impact of the project results on European society. With this movie, we hope to raise awareness among a wide audience for the importance of nanomedicine in treating neurodegenerative diseases in...
    Read more
  • Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

    B-SMART partner VIB announces the publication of a new paper in the journal EMBO Molecular Medicine. In it,  Prof. Roosmarijn Vandenbroucke and her research team report that tumor necrosis factor (TNF), via activation of its receptor TNFR1, is the main inflammatory upstream mediator of the with Alzheimer’s disease (AD) associated changes at...
    Read more
  • New blood test to detect early signs of Alzheimer's

    A team of Australian and Japanese scientists has developed a blood test to detect a toxic protein, amyloid beta, which is connected to Alzheimer’s disease. First tests were able to identify the protein with 90% accuracy. Amyloid beta builds up in the brain during the disease; by measuring the proportions of amyloid fragment in the blood, the...
    Read more
  • Refining B-SMART research and cooperation

    From 01 to 02 February 2018, the B-SMART consortium came together for its 2nd Progress Meeting in Malvern, UK to discuss and align the project’s scientific work and further collaboration. The meeting was hosted by B-SMART partner Malvern Instruments Ltd (Malvern) on their premises. The two meeting days were preceded by a workshop on Dynamic...
    Read more
  • USC video about their work in B-SMART

    The Alonso’s Lab has organized its annual mini-congress at the end of last year. This event is aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work. The video format was the preferred choice in most presentations. The scientific sessions were about...
    Read more